TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+5.28%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.69B
AUM Growth
+$2.69B
(+12%)
Cap. Flow
+$181M
Cap. Flow
% of AUM
6.73%
Top 10 Holdings %
Top 10 Hldgs %
49.42%
Holding
121
New
19
Increased
15
Reduced
14
Closed
13
Top Buys
| 1 |
Viatris
VTRS
|
$56.1M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$53.5M |
| 3 |
Johnson & Johnson
JNJ
|
$43.9M |
| 4 |
Alkermes
ALKS
|
$28.8M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$23M |
Top Sells
| 1 |
AbbVie
ABBV
|
$71.2M |
| 2 |
Gilead Sciences
GILD
|
$23.4M |
| 3 |
Perrigo
PRGO
|
$21.6M |
| 4 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$19.4M |
| 5 |
Heron Therapeutics
HRTX
|
$13.6M |
Sector Composition
| 1 | Healthcare | 86.5% |
| 2 | Real Estate | 3.17% |
| 3 | Financials | 1.57% |
| 4 | Technology | 0.04% |
| 5 | Industrials | 0% |
